Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)

Article English OPEN
Heller, S.; Amiel, S.; Campbell, M.; Choudhary, P.; Cooper, C.; Dimairo, M.; Elliott, J.; Hammond, P.; Lee, E.; Lindsay, R.; Waugh, N.; White, D.;
  • Publisher: BMJ Publishing Group: BMJ

Objective\ud To compare the effectiveness of insulin pumps with\ud multiple daily injections for adults with type 1\ud diabetes, with both groups receiving equivalent\ud training in flexible insulin treatment.\ud Design\ud Pragmatic, multicentre, open label, parallel gr... View more
  • References (23)
    23 references, page 1 of 3

    The Diabetes Control and Complications Trial Research Group. The efect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. doi:10.1056/ NEJM199309303291401.

    2 DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746-9. doi:10.1136/bmj.325.7367.746.

    3 Mühlhauser I, Bruckner I, Berger M, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 1987;30:681-90. doi:10.1007/BF00296989.

    4 Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53. doi:10.1056/NEJMoa052187.

    5 Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with Type 1 diabetes: better care through technology. Diabet Med 2001;18:864-70. doi:10.1046/j.1464-5491.2001.00626.x.

    6 Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-8. doi:10.2337/ diacare.25.3.593.

    7 Riemsma R, Corro Ramos I, Birnie R, et al. Type 1 diabetes: Integrated sensor-augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system), a systematic review and economic evaluation. Health Technol Assess 2016;20:v-xxxi. doi:10.3310/ hta20170.

    8 National Institute for Health and Care Excellence (NICE). Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE technology appraisal guidance 151. 2008. Available from: https://www.nice.org.uk/guidance/ta151

    9 Diabetes UK. The United Kingdom Insulin Pump Audit- Service Level Data Online Source. 2013. Available from: https://jdrf.org.uk/ wp-content/uploads/2015/10/The_United_Kingdom_Insulin_Pump_ Audit_May_2013.pdf

    10 Pickup J. Insulin pumps. Int J Clin Pract Suppl 2011;170:16-9. doi:10.1111/j.1742-1241.2010.02574.x.

  • Metrics
Share - Bookmark